Avid Bioservices
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1981-01-01
- Employees
- 371
- Market Cap
- $654.2M
- Website
- http://avidbio.com
- Introduction
Avid Bioservices, Inc. engages in clinical and commercial manufacturing of biologics. It focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
Cell and Gene Therapy CDMO Market Set to Reach $74 Billion by 2034, Growing at 28% CAGR
The global cell and gene therapy CDMO market is projected to grow from $8.07 billion in 2025 to $74.03 billion by 2034, expanding at a robust CAGR of 27.92% as demand for advanced therapies increases.
Clinical Trial Experts Outline Strategies to Combat Patient Retention and Manufacturing Challenges
Patient retention remains a critical challenge in clinical trials, with 30% dropout rates leading to increased costs and delayed market entry, as discussed at the OCT & CTS Nordics meeting in Copenhagen.
APAC Clinical Services Market Set to Reach $140 Billion by 2031 as Region Emerges as Trial Powerhouse
The Asia-Pacific region has become a clinical trial powerhouse, contributing nearly 50% of new global trial activity and offering diverse patient demographics for expedited enrollment.